Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 7, 2008, Pages 1790-1799

  Hussain, Shehnaz K ^a,c   Madeleine, Margaret M ^a   Johnson, Lisa G ^a   Du, Qin ^a   Malkki, Mari ^a   Wilkerson, Hui Wen ^b   Farin, Federico M ^b   Carter, Joseph J ^a   Galloway, Denise A ^a   Daling, Janet R ^a   Petersdorf, Effie W ^a   Schwartz, Stephen M ^a  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW; UTERINE CERVIX CANCER; VULVA CANCER;

ADOLESCENT; ADULT; AGED; ALLELES; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; INTERLEUKIN-2; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; SMOKING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS; WASHINGTON; YOUNG ADULT;

EID: 53549127840     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2753     Document Type: Article

References (67)

1. zurHausen HT. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
2. Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997;89:1516-23.
3. Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 1997;90:748-54.
4. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;11:20-8.
5. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992;135:180-9.
6. Bosch FX, Munoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750-8.
7. Herrero R, Brinton LA, Reeves WC, et al. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 1989;81:205-11.
8. Szarewski A, Jarvis MJ, Sasieni P, et al. Effect of smoking cessation on cervical lesion size. Lancet 1996;347:941-43.
9. Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004;96:99-106.
10. Frisch M, Biggar IJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.
11. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls - impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000;154:127-34.
12. Halpert R, Fruchter RG, Sedlis A, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986;68:251-8.
13. Nakagawa M, Stites DP, Farhat S, et al. Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis 1997;175:927-31.
14. Eiben GL, Velders MP, Kast WM. The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy. Adv Cancer Res 2002;86:113-48.
15. Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997;89:245-50.
16. Stanley MA. Immunobiology of papillomavirus infections. J Reprod Immunol 2001;52:45-59.
17. Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev 1997;10:742-80.
18. de Gruijl TD, Bontkes HJ, Walboomers JM, et al. Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Cancer Res 1998;58:1700-06.
19. Al-Saleh W, Giannini SL, Jacobs N, et al. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol 1998;184:283-90.
20. Li Q, Aubrey MT, Christian T, Freed BM. Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam Appl Toxicol 1997;38:158-65.
21. Geiselhart LA, Christian T, Minnear F, Freed BM. The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression. Toxicol Appl Pharmacol 1997;143:30-6.
22. McCue JM, Link KL, Eaton SS, Freed BM. Exposure to cigarette tar inhibits ribonucleotide reductase and blocks lymphocyte proliferation. J Immunol 2000;165:6771-5.
23. Madretsma GS, Donze GJ, van Dijk AP, et al. Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-α by human mononuclear cells. Immunopharmacology 1996;35:47-51.
24. Ouyang Y, Virasch N, Hao P, et al. Suppression of human IL-1β, IL-2, IFN-γ, and TNF-α production by cigarette smoke extracts. J Allergy Clin Immunol 2000;106:280-7.
25. Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001;72:1444-50.
26. Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003;95:E2.
27. Sellors JW, Karwalajtys TL, Kaczorowski JA, et al. Prevalence of infection with carcinogenic human papillomavirus among older women. CMAJ 2002;167:871-3.
28. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144:207-13.
29. Yang Q, Khoury MJ, Flanders WD. Sample size requirements in case-only designs to detect gene-environment interaction. Am J Epidemiol 1997;146:713-20.
30. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996;5:541-8.
31. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-21.
32. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-46.
33. Hartge P, Brinton LA, Rosenthal JF, et al. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984;120:825-33.
34. Carter JJ, Madeleine MM, Shera K, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 2001;61:1934-40.
35. Madeleine MM, Anttila T, Schwartz SM, et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007;120:650-55.
36. Seattle SNPs. NHLBI Program for Genomic Applications, UW-FHCRC, Seattle, WA (URL: http://pga.gs.washington.edu) [August, 2003].
37. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-20.
38. Garcia-Closas M, Egan KM, Abruzzo J, et al. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 2001;10:687-96.
39. Umbach DM, Weinberg CR. Designing and analysing case-control studies to exploit independence of genotype and exposure. Stat Med 1997;16:1731-43.
40. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
41. French B, Lumley T, Monks SA, et al. Simple estimates of haplotype relative risks in case-control data. Genet Epidemiol 2006;30:485-94.
42. Sasson IM, Haley NJ, Hoffmann D, et al. Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med 1985;312:315-6.
43. Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Van Assche FA. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995;39:34-8.
44. Barton SE, Maddox PH, Jenkins D, et al. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet 1988;2:652-4.
45. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000;181:939-45.
46. Kuhn RM, Karolchik D, Zweig AS, et al. The UCSC Genome Browser Database: Update 2007. Nucleic Acids Res 2007;35:D668-73.
47. Siepel A, Bejerano G, Pedersen JS, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005;15:1034-50.
48. Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998;29:932-48.
49. MacMillan ML, Radloff GA, Kiffmeyer WR, et al. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation 2003;76:1758-62.
50. Ahn KS, Aggarwal BB. Transcription factor NF-κB: a sensor for smoke and stress signals. Natural products and molecular therapy. Ann N Y Acad Sci 2005;1056:218-33.
51. Zeidler R, Albermann K, Lang S. Nicotine and apoptosis. Apoptosis 2007;12:1927-43.
52. Bontkes HJ, de Gruijl TD, van den Muysenberg AJC, et al. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia. Int J Cancer 2000;88:92-8.
53. Todd RW, Roberts S, Mann CH, et al. Human papillomavirus (HPV) type 16-specific CD8+ T cell responses in women with high grade vulvar intraepithelial neoplasia. Int J Cancer 2004;108:857-62.
54. Davidson EJ, Boswell CM, Sehr P, et al. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res 2003;63:6032-41.
55. Thorisson GA, Smith AV, Krishnan L, Stein LD. The International HapMap Project Web site. Genome Res 2005;15:1591-3.
56. Schumacher JM, Lee K, Edelhoff S, Braun RE. Distribution of Tenr, an Rna-binding protein, in a lattice-like network within the spermatid nucleus in the mouse. Biol Reprod 1995;52:1274-83.
57. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007;315:525-8.
58. Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 2006;7:98-108.
59. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
60. Garcia-Closas M, Rothman N, Lubin J. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size. Cancer Epidemiol Biomarkers Prev 1999;8:1043-50.
61. Rothman N, Garcia-Closas M, Stewart WT, Lubin J. The impact of misclassification in case-control studies of gene-environment interactions. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. France IARC Lyon; 1999. p. 89-96.
62. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002;89:229-40.
63. Lai HC, Chang CC, Lin YW, et al. Genetic polymorphism of the interferon-g gene in cervical carcinogenesis. Int J Cancer 2005;113:712-8.
64. Stanczuk GA, Sibanda EN, Perrey C, et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 2001;94:792-4.
65. Stanley MA. Human papillomavirus vaccines. Rev Med Virol 2006;16:139-49.
66. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - a randomized trial. JAMA 2007;298:743-53.
67. Schiller JT, Davies P. Science and society - delivering on the promise: HPV vaccines and cervical cancer. Nat Rev Microbiol 2004;2:343-7.